These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6294139)

  • 1. Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.
    Canfield WM; Kisiel W
    J Clin Invest; 1982 Dec; 70(6):1260-72. PubMed ID: 6294139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.
    Marlar RA; Griffin JH
    J Clin Invest; 1980 Nov; 66(5):1186-9. PubMed ID: 6253526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal titer of functional and immunoreactive protein-C inhibitor in plasma of patients with congenital combined deficiency of factor V and factor VIII.
    Suzuki K; Nishioka J; Hashimoto S; Kamiya T; Saito H
    Blood; 1983 Dec; 62(6):1266-70. PubMed ID: 6315113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on human protein C inhibitor in normal and Factor V/VIII deficient plasmas.
    Gardiner JE; Griffin JH
    Thromb Res; 1984 Nov; 36(3):197-203. PubMed ID: 6549082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of coagulant antigens and inhibition of activated protein C in combined factor V VIII deficiency.
    Giddings JC; Sugrue A; Bloom AL
    Br J Haematol; 1982 Nov; 52(3):495-502. PubMed ID: 6812616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined factor V and factor VIII deficiency with normal protein C and protein C inhibitor. A family study.
    Rahim Adam KA; Al Rahman F; el Seed A; Karrar ZA; Gader AM
    Scand J Haematol; 1985 May; 34(5):401-5. PubMed ID: 2990022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of protein C and protein C inhibitor to warfarin therapy in patient with combined deficiency of Factors V and VIII.
    Bern MM; Suzuki K; Mann K; Tracy P; Hoyer L; Jensen W; Gallivan M; Arkin C; Davis G
    Thromb Res; 1984 Dec; 36(6):485-95. PubMed ID: 6098970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
    Radtke KP; Stief TW; Heimburger N
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C inhibitor.
    Suzuki K
    Semin Thromb Hemost; 1984 Apr; 10(2):154-61. PubMed ID: 6330903
    [No Abstract]   [Full Text] [Related]  

  • 10. Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.
    Kisiel W
    J Clin Invest; 1979 Sep; 64(3):761-9. PubMed ID: 468991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined factor V/VIII deficiency: a case report including levels of factor V and factor VIII coagulant and antigen as well as protein C inhibitor.
    Brown JM; Selik NR; Voelpel MJ; Mammen EF
    Am J Hematol; 1985 Dec; 20(4):401-7. PubMed ID: 3934961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.
    Heeb MJ; España F; Geiger M; Collen D; Stump DC; Griffin JH
    J Biol Chem; 1987 Nov; 262(33):15813-6. PubMed ID: 2824468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C inhibitor. Purification from human plasma and characterization.
    Suzuki K; Nishioka J; Hashimoto S
    J Biol Chem; 1983 Jan; 258(1):163-8. PubMed ID: 6294098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
    Gale AJ; Sun X; Heeb MJ; Griffin JH
    Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.
    Chiu HC; Whitaker E; Colman RW
    J Clin Invest; 1983 Aug; 72(2):493-503. PubMed ID: 6348091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals.
    Nicolaes GA; Thomassen MC; Tans G; Rosing J; Hemker HC
    Blood Coagul Fibrinolysis; 1997 Jan; 8(1):28-38. PubMed ID: 9105635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
    Koedam JA; Meijers JC; Sixma JJ; Bouma BN
    J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and complexation of activated protein C by two major inhibitors in plasma.
    Heeb MJ; España F; Griffin JH
    Blood; 1989 Feb; 73(2):446-54. PubMed ID: 2917184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined congenital deficiency of factor V and factor VIII. Report of a further case with some considerations on the hetereditary transmission of this disorder.
    Girolami A; Gastaldi G; Patrassi G; Galletti A
    Acta Haematol; 1976; 55(4):234-43. PubMed ID: 816163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of protein C and combined deficiency of factors V and VIII.
    Vicente V; Alberca I; Lopez Borrasca A
    Br J Haematol; 1983 Apr; 53(4):686. PubMed ID: 6687552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.